financetom
Business
financetom
/
Business
/
Quebecor Posts 20% Increase In Q1 Adjusted Income on Benefits of Freedom Mobile Acquisition
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Quebecor Posts 20% Increase In Q1 Adjusted Income on Benefits of Freedom Mobile Acquisition
May 9, 2024 3:50 AM

06:41 AM EDT, 05/09/2024 (MT Newswires) -- Quebecor (QBR-A.TO, QBR-B,TO) on Thursday reported a nearly 20% increase in first-quarter adjusted income, driven by higher revenues from the telecommunications business segment following the acquisition of Freedom Mobile in 2023.

First-quarter adjusted income from operating activities came in at $163.1 million, or $0.71 per share, up from $136 million, or $0.59 per share. Net income attributable to shareholders increased to $173.2 million, or $0.75 per share, from $120.9 million, or $0.52 per share.

Revenues also jumped 22% to $1.36 billion from $1.12 billion, while adjusted EBITDA rose 26% to $559.5 million from $442.8 million.

The telecommunications segment reported a nearly 28% rise in revenues and a 21% increase in adjusted EBITDA, reflecting the contribution of the Freedom Mobile acquisition. Quebecor's telecommunications unit Videotron acquired Freedom Mobile from Shaw Communications on April 3, 2023, for $2.07 billion in cash.

In addition, Quebecor's board appointed Sylvie Lalande as chair, succeeding Brian Mulroney, who passed away on Feb. 29. Andre Brosseau was appointed vice chair of the board.

Quebecor fell 0.9% to $28.75 per share on Wednesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
After two-year wait, Danone gears up for Olympics health-kick ahead of Paris Games
After two-year wait, Danone gears up for Olympics health-kick ahead of Paris Games
Apr 18, 2024
LONDON, April 18 (Reuters) - Danone, whose CEO first reached out to the International Olympic Committee (IOC) in mid-2022 to get involved, is betting on the Paris Games' focus on health and nutrition to boost summer sales of its yoghurts and plant-based products. Dozens of major French companies have emerged as first-time partners of the Olympic Games this year, hoping...
Market Chatter: Tesla Lays Off 300 Temporary Workers in Germany
Market Chatter: Tesla Lays Off 300 Temporary Workers in Germany
Apr 18, 2024
07:51 AM EDT, 04/18/2024 (MT Newswires) -- Tesla (TSLA) has let go of 300 subcontracted workers in Germany, Reuters reported Thursday, citing a spokesperson for the EV maker. As far as we are aware, our contractual partner has already been able to transfer the majority of these de-registered temporary workers to new employment with other customers, Tesla said, according to...
ARS Pharmaceuticals Insider Sold Shares Worth $928,005, According to a Recent SEC Filing
ARS Pharmaceuticals Insider Sold Shares Worth $928,005, According to a Recent SEC Filing
Apr 18, 2024
07:46 AM EDT, 04/18/2024 (MT Newswires) -- Tanimoto Sarina, 10% Owner, CHIEF MEDICAL OFFICER, on April 16, 2024, sold 100,000 shares in ARS Pharmaceuticals ( SPRY ) for $928,005. Following the Form 4 filing with the SEC, Tanimoto Sarina has control over a total of 12,546,116 shares of the company, with 3,276,854 shares held directly and 9,269,262 shares controlled indirectly....
Cerevel's Parkinson's disease drug improves symptom control in late-stage trial
Cerevel's Parkinson's disease drug improves symptom control in late-stage trial
Apr 18, 2024
April 18 (Reuters) - Cerevel Therapeutics ( CERE ) said on Thursday its Parkinson's disease drug improved symptom control in patients when tested as an add-on therapy, meeting the main goal in a late-stage study. The trial, which enrolled 507 adults, tested Cerevel's tavapadon as an add-on therapy to levodopa, the standard of care for the nervous system disorder that...
Copyright 2023-2025 - www.financetom.com All Rights Reserved